Concall Summary: Hero MotoCorp Q4FY20

Reading Time: 2 minutes

Participants:

  • Systematix
  • Axis Capital
  • Nomura Securities
  • JP Morgan
  • Antique
  • Equirus Capital
  • CLSA
  • Avendus Capital
  • Kotak Securities
  • Motilal Oswal Financial
  • Sundaram Mutual Fund
  • Edelweiss Securities
  • ICICI Securities

Business Overview:

  • Q4FY20 Revenue at Rs 6,334 crore vs Rs 7,953 crore YoY
  • Q4FY20 PAT at Rs 605 crore vs Rs 771 crore YoY

ConCall highlights:

  • Lost sales of 2.3 lakh unit in the last 9 days of March, including this sales would have been Rs 7,400 crore
  • EBITDA margin at 10.6%; excluding one-off impact margin would have been 13.5%. Company has provided support of Rs 110 crore to dealers to liquidate BS-4 vehicle; 10,000-15,000 per vehicle. Company has also provided for fiscal benefits to the tune of Rs 67 crore
  • Company has maintained market share in entry and deluxe segment; newly launched Xtreme 160R would improve its position in premium segment. Hero will start dispatch Xtreme 16R in couple of weeks time
  • Brought down the dealer inventory by 5.5 lakh units during this financial year
  • All pants are now operation and volumes are getting ramped up gradually. Raw materials are available from vendors; 90% outlets are open now
  • Many of the dealers have reached 70-80% pre-Covid volume
  • Demand is gradually picking up; enquiries have increased and conversion rate is very good
  • Financing penetration has increased. Financed portion for FY20 was 46% vs 41% in FY19; 40%+ for Q1FY21. Liquidity position is strong in Hero FinCorp as the company recently raised money
  • 43% of Hero’s sales in FY20 went through financing and out of that Hero FinCorp’s share was 46% 
  • Hero has increased prices in the month of May to improve dealer margin
  • Labor availability has been improving as migrants workers are flowing back 
  • Rural and semi urban likely to perform better than urban market this year. Close to 50% business comes from rural India
  • Hero started this financial year with 5.5 lakh BS-6 vehicle inventory
  • Company has reduced its capex guidance for FY21 to Rs 600 crore from Rs 1,000 crore projected earlier but not reduced R&D expenses
  • Market share in scooter segment will improve in FY21 as newly launched product has received good response and many new products are lined up for launch
  • Spare parts revenue for Q4FY20 was Rs 751 crore and for FY20 was Rs 2,896 crore
  • All the BS-4 vehicle at dealers level have been sold
Also Read on FinMedium:  Concall Summary: Alembic Pharmaceuticals Ltd Q1FY21

Read more concall summaries here.

Image Source: FindLogoVector.com

Disclaimer: The opinions expressed in this publication are those of the authors. They do not purport to reflect the opinions or views of the FinMedium or its members. The presentation of material therein does not imply the expression of any opinion whatsoever on the part of the FinMedium concerning the legal status of any company, country, area, or territory or of its authorities. For more info. please read our ToU & Privacy Policy here. If you have any concerns regarding this post, please reach out to us at finmedium@gmail.com

Every Wednesday and Saturday, we send Info-Graphic and FinMedium Weekly Digest newsletters to our 25000+ Subscribers.

Join Them Now!


Karan Sharma

Karan Sharma

The Concall Summary Guy | CFA | Investor
Please Share Now :)